Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Provision of Community Intravenous Therapy (including Bisphosphonates) Service to be delivered to Greater Manchester Integrated Care Board.
The Contract to be awarded as a result of this Procurement will have an initial term of three years commencing from 01 April 2026.
The Authority will also have the option to extend the initial term of the Contract to a maximum term of five years to 31 March 2031 (3 years + 2 years).
The anticipated, maximum total contract value (including any potential extensions) is £3,087,540.
The indicative overall total contract value is made of £1,852,524 for the three years of contract (equal to £617,508 per annum) and £1,235,016 for the two-year extension.
This is a Provider Selection Regime (PSR) open competitive intention to award notice, this notice serves as an intention to award under the PSR.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Mastercall Healthcare | 05224356 | ~£3,087,540 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 2 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,800 days (≈4.9 yrs) | £3,087,540 | 2 | active |
Weightings from the notice.
Government spending data: This supplier has received £4,642,504 in 125 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England (2014-04-30 to 2025-10-31). View full payment history →
Published by the buyer on this notice. Check the original notice — details change and are not updated here.